Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

Abstract Heart failure (HF) does not occur in a vacuum and is commonly defined and exacerbated by its co‐morbid conditions. Neurohormonal imbalance and systemic inflammation are some of the key pathomechanisms of HF but also commonly encountered co‐morbidities such as arterial hypertension, diabetes...

Full description

Bibliographic Details
Main Authors: Ana Jorbenadze, Marat Fudim, Felix Mahfoud, Phillip B. Adamson, Tarek Bekfani, Rolf Wachter, Horst Sievert, Piotr P. Ponikowski, John G. F. Cleland, Stefan D. Anker
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Heart Failure
Comorbidities
Autonomic Nervous System
Neuromodulation
Online Access:https://doi.org/10.1002/ehf2.13361

Similar Items

Similar Items